COMMUNIQUÉS West-GlobeNewswire

-
Nurix Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
13/06/2025 -
23andMe Reaches Agreement for Sale of Business to TTAM Research Institute Following Final Round of Bidding in Court-Approved Sale Process
13/06/2025 -
Rapid Micro Biosystems Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
13/06/2025 -
Vaxart Announces Preliminary Results of Annual Meeting of Stockholders
13/06/2025 -
MSP Recovery Law Firm Files Class Action Lawsuit Against Ralph Navarro and FYI Yachts for Alleged Fraud, Racketeering, and Consumer Abuse
13/06/2025 -
KFSHRC Advances Smart Hospital Transformation through AI and Emerging Technologies
13/06/2025 -
13171229 B.C. Ltd. and Launchit Solutions Inc. Announce Execution of Business Combination Agreement and Launchit’s Concurrent Financing
13/06/2025 -
Tiziana Life Sciences Expands Phase 2 Clinical Trial of Intranasal Foralumab with Commencement of First Patient Dosing at Weill Cornell Multiple Sclerosis Center
13/06/2025 -
The Dental Medical Convergence Announces Featured Article and Podcast Interview on KevinMD Highlighting Dangers of Dental Infections
13/06/2025 -
PolTREG Establishes U.S. Subsidiary Immuthera to Advance International Development Strategy
13/06/2025 -
IPSEN - Achats effectués dans les conditions de l'Article 5 du Règlement MAR - Semaine 23 - 2025
13/06/2025 -
IPSEN - Buy-back programme - Art 5 of MAR - Week 23 - 2025
13/06/2025 -
Sunset Social Club Opens as West Hollywood’s First Luxury Cannabis Lounge for Members Only
13/06/2025 -
Biomea Fusion Presents Updated Preliminary Clinical Data for Covalent FLT3 Inhibitor BMF-500 in Relapsed or Refractory Acute Leukemia at EHA 2025
13/06/2025 -
ORLADEYO® (berotralstat) Approved in Colombia
13/06/2025 -
Tonix Pharmaceuticals Announces Appointment of Commercial Industry Veteran, James “Jim” Hunter, to Board of Directors
13/06/2025 -
Fractyl Health to Present New Preclinical Data from its Rejuva® Smart GLP-1™ Pancreatic Gene Therapy Platform at the American Diabetes Association's 85th Scientific Sessions
13/06/2025 -
Arvinas Presents Preclinical Data for PROTAC BCL6 Degrader, ARV-393, at the European Hematology Association 2025 Congress
13/06/2025 -
AccuStem Sciences, Inc. Announces Chairman Purchase of Shares
13/06/2025
Pages